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a b s t r a c t
We report a simple and low cost methodology to synthesize sodium oleate coated magnetite nano-
particles for hyperthermia applications. The system consists of oleate coated magnetite nanoparticles
with large susceptibility (1065 emu/gT), induced by the dipolar inter-particle interaction, with a magnetic
core diameter in the 6 nm–12 nm size range. In aqueous medium, the nanoparticles agglomerate to form a
monodisperse system, exhibiting a mean hydrodynamic diameter of 60.6 nm74.1 nm, with a low average
polydispersity index of 0.12870.003, as required for intravenous applications. The system exhibits
promising efﬁciency for magnetic hyperthermia, with a speciﬁc absorption rate of 14 W/g at a low ﬁeld
amplitude of 15.9 kA/m and frequency of 62 kHz. In a 50 mg/mL density in 1 mL, the temperature rises to
42.5 1C in 1.9 min.
& 2014 Elsevier B.V. All rights reserved.
1. Introduction
Cancer is one of the most challenging problems of modern
medicine and a leading cause of death worldwide, accounted for
7.6 million deaths (around 13% of all-cause mortality) in 2008.
Projections estimate 13.1 million deaths from cancer in 2030 [1].
Alternative techniques for cancer treatment have been widely
studied in the last years to increase the effectiveness of currently
available therapies, such as chemotherapy or radiotherapy, and
reduce their side effects [2,3].
Hyperthermia is a promising approach for cancer therapy.
Different techniques have been proposed to generate heat at the
tumor site and produce apoptosis of tumor cells that are more
sensitive to high temperatures than healthy cells [2,4].
The most common treatments with hyperthermia require
temperature elevations to a range between 42 and 45 1C which
is sufﬁcient to destroy cancer cells without causing damage to
normal tissue [5].
Much effort has been made to improve hyperthermia techni-
ques for clinical applications, leading to the development of
magnetic hyperthermia. This technique involves the administra-
tion of magnetic particles into the tumor or target tissue followed
by exposure to an external AC magnetic ﬁeld that causes the
particles to heat because of their capacity to convert the energy
absorbed from a high-frequency magnetic ﬁeld into thermal
energy mostly via relaxation and hysteresis losses [5–7].
Whereas the majority of hyperthermia modalities including
microwave, laser and ultrasonic wave-based treatments are restricted
in their utility because of unwanted heating of healthy tissue,
magnetic hyperthermia has the advantage to selectively target the
tumor cells [4,8].
The frequency of the AC magnetic ﬁeld has to be higher than
50 kHz, to avoid neuromuscular electrostimulation, and lower
than 10 MHz for appropriate penetration into the body [6]. High
amplitude and frequency of the applied ﬁeld may generate eddy
currents and cause non-selective heating of the biological tissue,
so a limit on the amplitude of magnetic ﬁeld was established
between 8 and 16 kA/m [2].
In addition to the potential use in hyperthermia, magnetic
particles have attracted much attention due to their current and
novel biomedical applications such as magnetic resonance ima-
ging, tissue engineering, magnetofection, and cellular labeling/cell
separation and magnetically targeted drug delivery [9–13].
For clinical applications, these particles must be biocompatible,
non-toxic, non-immunogenic and water-based [14]. Several stu-
dies report a vast range of magnetic materials that can be applied
in biotechnology. Iron oxide particles represented by magnetite
(Fe3O4) and maghemite (γ-Fe2O3) are considered promising can-
didates because they present biocompatibility, high saturation
magnetization, stable magnetic response, higher resistance to
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oxidation than other metal compounds and relative easiness to
functionalize with polymers or functional groups [15,16].
The size also plays a key role. Nanoparticles with small diameter
and narrow size distribution are required for biomedical applications
in general. It is currently accepted that the diameter of the nano-
particles should be in the 10–100 nm size range, in order to avoid
rapid removal from systemic circulation by extravasation, renal
clearance or uptake into the reticuloendothelial system, and emboli
within the capillaries [17,18].
For magnetic hyperthermia applications, the need to control the
particle size is further enhanced, in order to optimize the energy
transfer to the biologic tissue. High polydispersity of the nanoparticles
size diminishes the magnetic heating that can be achieved [19,20].
Due to the high surface area to volume ratio, and the strong
dipole–dipole interactions and van der Waals attractive forces,
magnetic nanoparticles tend to agglomerate and form large clusters
resulting in increased particle size [21].
Surface coating of the nanoparticles prevents aggregation and
may provide colloidal stability by steric and/or electrostatic
repulsion [22].
Numerous coating materials have been reported previously,
such as polymers (e.g., polyethylene glycol, Pluronics, dextran,
chitosan), inorganic materials (e.g., silica, alumina), and liposome
and fatty acids [22–24].
Previous works report that oleic acid and sodium oleate have
high afﬁnity to the surface of iron oxide particles, being effective in
the stabilization of nanoparticles by steric repulsion. It is possible
to obtain iron oxide nanoparticles coated with monolayers of
these surfactants, which are dispersible in organic solvents, or
bilayers that can be dispersed in water. In the latter case, the
primary layer is ﬁrst adsorbed onto the surface of the nanoparti-
cles through chemical bonds between the carboxylic acid head
groups of the surfactant molecules and the particle surface. The
secondary layer is adsorbed onto the primary layer through
hydrophobic interactions. Thus, the outermost layer provides
hydrophilic groups that make the magnetic nanoparticles disper-
sible in aqueous solutions [25–29].
We note that toxicity evaluation is a mandatory issue. Sun et al.
[30] reported that magnetite nanoparticles coated with sodium
oleate had low toxicity and a better biocompatibility than magne-
tite nanoparticles coated with polyethylene glycol. Jain et al.
evaluated the distribution, clearance and biocompatibility of iron
oxide magnetic nanoparticles coated with oleic acid and Pluronics
in rats [31]. They found that the coated nanoparticles did not cause
long-term changes in the liver enzyme levels, or induce oxidative
stress, and thus can be safely used for drug delivery and imaging
applications without signiﬁcant levels of toxicity.
We presently report the synthesis of superparamagnetic
sodium oleate coated magnetite nanoparticles, using a simple
and low cost co-precipitation methodology, with no organic
solvents. In the aqueous medium the nanoparticle system has a
narrow size distribution, and large initial susceptibility, as required
for high efﬁciency hyperthermia applications.
2. Materials and methods
Iron (III) chloride hexahydrate (FeCl3 6H2O, 99%), iron (II)
sulphate heptahydrate (FeSO4 7H2O, 99%), ammonium hydroxide
(28–30% NH3), potassium bromide (KBr, 99%) and ethanol (C2H6O,
99%) were purchased from Vetec (Vetec Química Fina Ltda., Brazil).
Sodium oleate (C18H33NaO2, 82%) was acquired from Sigma
(Sigma-Aldrich Co. LLC., USA). Deionized water was prepared using
a DE-1800 water puriﬁcation system (Permution Ltda., Brazil).
The nanoparticles were synthesized by co-precipitation of Fe3þ
and Fe2þ salts using excess of ammonium hydroxide as previously
described [26,32]. In a typical synthesis, an aqueous solution
containing 0.12M of Fe3þ and 0.06M of Fe2þ was prepared by
dissolution of FeCl3 6H2O and FeSO4 7H2O in deionized water.
This solution was heated until 80 1C and stirred at 960 rpm
(Mechanical stirrer RW 20, IKA Labortechnik, Germany), followed
by rapid addition of 16 mL of NH4OH (28–30% NH3) solution. The
resulting suspension was vigorously stirred for 5 min. Then, 50 mL
of 0.06 M sodium oleate dispersion was added into the reaction
medium and continuously stirred for 25 min. At the end of the
process, a black precipitate was obtained and washed several
times with deionized water.
Finally, the procedure was repeated one more time by heating
the precipitate in aqueous suspension until 80 1C with stirring at
960 rpm and subsequent addition of 50 mL of a sodium oleate
dispersion with the same concentration as the previous one.
At this point, it was observed the formation of a stable dispersion
that was stirred for 25 min.
Additionally, bare magnetic particles were prepared by the
same process described above without the step of coating with
sodium oleate, in order to analyze its inﬂuence in the stabilization
of magnetic nanoparticles. While the sodium oleate coated parti-
cles showed colloidal aspect with good dispersion in water and no
evident sedimentation, the uncoated particles easily precipitated
to the bottom of the ﬂask.
3. Characterization
A particle size analyzer (ZetaPALS, Brookhaven Instruments)
was used to measure size distribution of the particles by dynamic
light scattering (DLS) technique. The zeta potential (ZP) was
determined in the same equipment.
X-ray diffraction (XRD) analysis (MiniFlex™II, Rigaku Co.) using
CuKα radiation (λ¼1.54060 Å) and 2θ scan range from 15–801 was
employed to study the crystal structure of the samples.
A vibrating sample magnetometer (VSM, custom-made) was
used to measure the magnetization of the samples at room
temperature with ﬁelds up to 1.2 T.
The structure, morphology and size of the crystallites were
investigated by selected area of electron diffraction (SAED) and
transmission electron microscopy (TEM) with an acceleration voltage
of 120 kV (Tecnai™ G2 Spirit TWIN, FEI). The samples were prepared
by placing one drop of the dispersion on a carbon coated copper grid
(300 mesh) and the size distributionwas calculated from 20 different
TEM images using an image analysis software (ImageJ) by measuring
the diameters of a total of 500 particles.
To study the interactions between surfactant and surface of the
particles, the Fourier transform infrared (FTIR) spectra were
recorded in transmittance mode over the wavenumber range of
400–4000 cm1 at a resolution of 1 cm1 (Spectrum 65 FTIR
Spectrometer, PerkinElmer Inc.). The powdered samples were
mixed with KBr and compressed into a pellet. For this particular
analysis, extra samples were produced by submitting the sodium
oleate coated particles to several washings with ethanol to remove
any surfactant molecule that was not chemically bound to the
surface of the particles.
The surfactant mass of coated particles was quantiﬁed by
thermogravimetric analysis (TGA) under argon atmosphere
(50 mL/min argon ﬂow) from room temperature up to 500 1C with
a heating rate of 10 1C/min (DTG-60H, Shimadzu). Differential
thermal analysis (DTA) was employed using the same parameters.
The evaluation of the particles potential application in mag-
netic hyperthermia was performed in an experimental setup
which produces an alternating magnetic ﬁeld with a frequency
of 62 kHz and amplitude of 15.9 kA/m or 200 Oe. The samples
were subjected to this ﬁeld for 600 s and their temperature was
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measured every second. In this test, the ferroﬂuid had a particle
concentration of approximately 50 mg/mL in 1 mL volume.
4. Results and discussion
4.1. Dynamic light scattering
The size distribution of the particles coated with sodium oleate
as measured by DLS is shown in Fig. 1a. The mean hydrodynamic
diameter of the nanoparticles was 60.6 nm74.1 nm. It was also
calculated that 10%, 50% and 90% of the nanoparticles were smaller
than 31.1 nm71.7 nm, 46.9 nm72.9 nm and 70.7 nm74.7 nm,
respectively.
The polydispersity index (PDI) was determined with an average
value of 0.12870.003. PDI less than 0.2 indicates a monodisperse
particulate system, as required for intravenous applications [33].
For the uncoated magnetic particles (Fig. 1b), the mean hydro-
dynamic diameter was 1230.4 nm7165.7 nm, and 10%, 50% and 90%
of the particles were smaller than 804.6 nm7367.3 nm, 1224.8 nm7
160.4 nm and 2020 nm7505.3 nm, respectively. The average value of
PDI was 0.41870.008 which characterizes a polydisperse particulate
system.
These results conﬁrm the essential role of sodium oleate coating
of the magnetite particles, leading to a monodisperse nanoparticle
system. The absence of surfactant led to an increase of about 20
times in the average particle hydrodynamic diameter, combined with
a considerable increment in polydispersity of more than three times.
Furthermore, for the same experimental conditions, the uncoated
particles exhibited a relative size variation much larger than the
coated nanoparticles, as observed in the standard deviation values,
indicating that the particle aggregation can take place differently for
each synthesis process when no surfactant is used.
4.2. Zeta potential
Zeta potential measurements for coated nanoparticles revealed
an average value of 32.971.6 mV, while for the bare micro-
particles this value was þ5.270.4 mV. The negative zeta potential
of the coated nanoparticles can be attributed to the negatively
charged carboxylate groups present in the sodium oleate. As the
pKa of carboxyl group is about 4, in aqueous medium with pH
higher than 6 virtually all carboxyl groups are ionized to the form
of carboxylate [34].
Zeta potential values found below 30 mV indicate that in
addition to stabilization by steric repulsion, the sodium oleate can
also stabilize the particles by electrostatic repulsion mechanisms.
Concerning the uncoated micropaticles, the positive and relatively
low zeta potential is related to the fact that the point of zero
charge (PZC) admitted for iron oxide particles is approximately 7.9.
Therefore, pH values below PZC lead to a positive zeta potential
which increases as the pH reduces [27].
4.3. X-ray diffraction
XRD patterns of the coated nanoparticles and standard mag-
netite (JCPDS Card no. 19-0629) are shown in Fig. 2a and b. The
analysis of the position and relative intensity of diffraction peaks
suggests the formation of magnetite nanoparticles. However, due
to the similarity between Fe3O4 and γ-Fe2O3 inverse spinel crystal
structure, this analysis may not distinguish which of the iron
oxides was actually formed [35]. One might think of using the
position of 440 peak in order to identify the predominant
magnetic phase. The 440 peak position is around 62.51 for
magnetite (JCPDS Card no. 19-0629) and 62.91 for maghemite
(JCPDS Card no. 39-1346). In our samples the 440 peak position
was 62.71 indicating either the presence of both magnetic phases,
or the formation of non-stoichiometric magnetite nanoparticles
with crystal defects.
For this reason we calculated the lattice parameter of the
crystals. The typical unit cell parameter reported for maghemite
is 8.34 Å and for magnetite is 8.39 Å [36]. The XRD data revealed
nanoparticles with lattice parameter of 8.383 Å that indicates the
synthesis of magnetite particles.
The lower value of lattice parameter observed in the nanopar-
ticles prepared by co-precipitation could be explained by oxidation
Fig. 1. Hydrodynamic size distribution of (a) coated nanoparticles and (b) uncoated
microparticles. Fig. 2. XRD patterns of (a) coated nanoparticles and (b) pure magnetite.
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of Fe2þ or existence of small amount of maghemite impurities,
especially at the surface of the particles [36,37].
The mean crystallite size, calculated from the XRD pattern, is
9.8 nm. This value is within the 25 nm size limit required for
superparamagnetism of magnetite at room temperature [38].
The DLS and XRD data indicate that in the aqueous phase the
crystallites agglomerate forming a monodisperse ferroﬂuid with
larger particles of 60 nm size.
4.4. Magnetization
The magnetization, as shown in Fig. 3, exhibits a value of about
64 emu/g at an external ﬁeld strength of 1.2 T. This is about 69% of
the bulk saturation magnetization of magnetite (92 emu/g).
Furthermore, the magnetization does not saturate for this large
value of the external ﬁeld strength. Both results are signatures of
small size superparamagnetic nanoparticle systems [28,35,39].
The reduced value of magnetization may be partially attributed
to dilution effects, caused by the presence of the sodium oleate
adsorbed layer.
Furthermore, the magnetic moment of small size nanoparticles
may have a relevant reduction due to the existence of spin canting
in the near surface region. This effect is more pronounced in small
particles, which have a much larger fraction of surface spins.
A disordered alignment of surface atomic spins may be induced by
the reduced surface coordination and the broken exchange bonds
in the near surface layers [40].
As shown in Fig. 3 remanence and coercivity are nearly zero,
indicating a typical superparamagnetic behavior. For biomedical
applications, superparamagnetic particles are preferred because
they do not retain any magnetization after removal of the
magnetic ﬁeld [4].
In order to model the magnetization curve we use a self-
consistent method which takes into account the existence of
nanoparticles with dimensions in the 5 nm to 18 nm size range,
with a size dispersion close to that found in the analysis of the
TEM images. The model also accounts for the dipolar interaction of
the nanoparticles assembled together in the VSM sample holder.
The basic phenomenology is based on the fact that in the
presence of an external magnetic ﬁeld each superparamagnetic
particle produces its own dipolar ﬁeld. Therefore each one of the
particles is under the action of the applied ﬁeld and the effective
dipolar ﬁeld produced by all the other particles.
The effective dipolar ﬁeld, for a given value of the applied ﬁeld,
depends on the relative position of the particles in the VSM
sample holder, the VSM sample holder shape, as well as on the
size dispersion.
Furthermore, the effective dipolar ﬁeld acting on a given
nanoparticle also depends on the diameters of the particles
distributed in the ﬁrst, second, third shells of particles around it.
We adopted a simplifying assumption.
The thermal average value of the magnetization is represented
by an average over a distribution of superparamagnetic spherical
crystallites, each of which is considered to be subjected to the
thermal average dipolar ﬁeld of the others.
For a given value of the external ﬁeld, the magnetization is
given by
MðHÞ ¼MS
Z
LfμðDÞHeff =kBTgf ðDÞ dD ð1Þ
where L is the Langevin function, MS is the saturation magnetiza-
tion, μðDÞ ¼ πMSD3=6 is the saturation magnetic moment of a
nanoparticle of diameter D, and f is a log-normal distribution
function.
Heff includes the external ﬁeld H, and an effective dipolar ﬁeld,
Heff ¼HþHd. We assumed that the effective dipolar ﬁeld Hd is
proportional to the thermal average dipolar ﬁeld produced by the
crystallite at a distance of one diameter,Hd ¼ 2α〈μðDÞ〉=D3. 〈μðDÞ〉 is
the thermal average magnetic moment of the crystallites with
diameter D.
We have assumed a reduction of the nanoparticles saturation
magnetic moment down to 70% of the saturation value. M(H), α
and the distribution function were adjusted self-consistently to ﬁt
the experimental data. We have found a narrow log-normal
distribution function
f ðdÞ ¼ 1ﬃﬃﬃﬃﬃﬃ
2π
p
sD
exp
 ln ðD=D0Þ2
2s2
" #
ð2Þ
with a standard deviation s¼0.24 and a D0¼8.0 nm median
diameter, with 83% of the particles with diameter in the 6 nm–
12 nm range, and an average diameter of 8.3 nm, in agreement
with the X-ray results and the TEM images size analysis.
In Fig. 3 we show the magnetization curve and susceptibility of
the coated magnetite nanoparticles. Notice that the theoretical
model (continuum line curves) reproduces quite well the experi-
mental results. Both the magnetization curve and the initial
susceptibility are well represented in the model theory.
We have found that the dipolar interaction between the
crystallites plays a key role in the magnetic response of the
nanoparticles to external ﬁeld in the mT range, and leads to the
large value of the initial susceptibility (1065 emu/gT). Without the
dipolar interaction, we have found that the initial susceptibility is
smaller than the measured value.
A discussion of the low ﬁeld effects is appropriate since
biomedical safety requires an AC magnetic ﬁeld strength of at
most 20 mT [2]. Also, the speciﬁc absorption rate for superpar-
amagnetic particles is proportional to the value of the magnetic
susceptibility at small ﬁeld strength [7].
Before entering the detailed discussion of this point, it is
instructive to consider qualitatively the phenomenology which leads
to the response of the nanoparticle system to a small strength
external ﬁeld. This is a key issue for hyperthermia applications.
Magnetite has a magnetic moment of 16:4μB per unit cell of
0.295 nm3 volume [41]. Thus a magnetite nanoparticle with diameter
D has a saturation magnetic moment given by μ0 ¼ 55:59πD3=6.
In the presence of a magnetic ﬁeld H, an isolated superpar-
amagnetic particle has a thermal average magnetic moment, along
the ﬁeld direction, which may be estimated [41] as
μ¼ μ0Lfμ0H=kBTg ð3Þ
Fig. 3. Magnetization curve of magnetite nanoparticles, full and open symbol
curves for the experimental results and continuum line for the theoretical model.
In the inset we show the susceptibility.
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where μ0 is the saturation moment, and L is the Langevin
function, LðxÞ ¼ cothðxÞ1=x.
A 9 nm diameter magnetite particle has a saturation magnetic
moment of around 7:07 104μB. At room temperature, an external
ﬁeld of 1 mT strength is enough to break the thermal relaxation
balance, producing a thermal average net magnetic moment of
around 1.0% of the saturation value. This amounts to stabilizing
92μB per 9 nm diameter particle. At a distance of 9 nm from the
particle center, the dipolar ﬁeld is about 8 mT. For small external
ﬁeld strengths, the dipolar ﬁeld produced by the 9 nm magnetite
nanoparticle at its neighborhood is of the order of magnitude of
the external ﬁeld.
Thus, in the low ﬁeld range, the dipolar effects cannot
be neglected. In the mT ﬁeld range, the susceptibility is to a
large extent controlled by the dipolar interaction between the
crystallites.
In order to investigate the impact of the dipolar interaction on the
magnetization, we have compared the ﬁnal result shown in Fig. 3
with simulations using the same algorithm, but with different size
distribution functions and effective dipolar interaction ﬁelds.
Using the same size distribution function (Eq. (2), with s¼0.24
and D0¼8.0 nm), but no dipolar contribution to the effective
(Heff ¼H), we have reproduced most of the magnetization curve,
except in the low ﬁeld range. The initial susceptibility was found to
be only 61% of the measured value.
We have also checked monodisperse nanoparticle systems with
size in the 6 nm–12 nm range. Without dipolar interaction, a 9 nm
particle system (s¼ 0:01 and a D0¼9.0 nm) has an initial suscept-
ibility of 713 emu/gT, which is about 66% of the measured value.
In order to reproduce the large initial susceptibility value, a
large diameter monodisperse particle system (s¼0.01 and a
D0¼10.3 nm) is required. However, this is not appropriate. In this
case the magnetization saturates too early, at an external ﬁeld
value of about 500 mT.
A previous report has indicated that for nanoparticle systems
with similar diameter size distribution, the dipolar interaction
leads not only to larger initial susceptibility, but also to a small
coercivity of 22 mT [42].
The dipolar effects in our coated samples are smaller due to the
oleate bilayer, which leads to a relevant decrease in the average
particle density. However, it is large enough to increase the
susceptibility by a factor of almost two.
4.5. Transmission electron spectroscopy
Fig. 4 shows two transmission electron microscopy (TEM)
pictures, selected from a total of 20 images used to investigate
the size distribution of the oleate coated magnetite nanoparticles.
The size histogram, including a total of 500 nanoparticles,
shows magnetite nanoparticles with dimensions in the 5 nm–
18 nm size range, and corresponds to a log-normal distribution
with median diameter of 9.8 nm, standard deviation s¼0.244, and
an average diameter of 10.01 nm.
This narrow size distribution, with about 80% of the nanopar-
ticles in the 6 nm–12 nm range of diameters, is in good agreement
with the crystallite size (9.8 nm) estimated from the X-ray
diffractogram.
From the SAED pattern of the synthesized sample shown in
Fig. 5, the d-spacings corresponding to the respective Miller
indices (hkl) were determined as being 4.86 Å (111), 2.97 Å
(220), 2.52 Å (311), 2.08 Å (400), 1.69 Å (422), 1.61 Å (511) and
1.47 Å (440). These values were close to those found in standard
magnetite (JCPDS Card no. 19-0629) which are 4.85 Å (111), 2.97 Å
(220), 2.53 Å (311), 2.10 Å (400), 1.71 Å (422), 1.62 Å (511) and
1.48 Å (440). The diffraction pattern is in agreement with the
XRD data.
4.6. Fourier transform infrared spectroscopy
FTIR spectra of the prepared samples are presented in Fig. 6.
Spectral bands with a maximum transmittance at 437 cm1 and
580 cm1 correspond, respectively, to the vibration of the Fe3þ–O
and Fe2þ–O bonds in the crystalline lattice of Fe3O4 [43].
Fig. 4. TEM image and size distribution histogram of oleate coated nanoparticles.
Fig. 5. Selected area electron diffraction (SAED) pattern of oleate coated nanoparticles.
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The bands at 1405 cm1 and 1554 cm1 can be ascribed to the
symmetric νs(COO) and asymmetric νas(COO) carboxylate
stretches. The sharp bands at 2922 cm1 and 2851 cm1 are
attributed to asymmetric and symmetric C–H vibrations of the
methylene groups.
During the preparation of Fe3O4 nanoparticles by the chemical
co-precipitation, their surfaces may be covered with hydroxyl
groups in an aqueous environment. Thus, the characteristic bands
of hydroxyl groups, 1630 cm1 and 3405 cm1, appeared in the
FTIR spectra [26,44,45].
The spectrum in Fig. 6b shows the presence of bands corre-
sponding to CH2 and COO groups, suggesting that the sodium
oleate is actually chemically bound to the surface of the magnetic
nanoparticles.
On the other hand, the band assigned to the asymmetric vibration
of carboxylate group shifted down to 1520 cm1 and had an
intensity reduction, indicating that there were oleate molecules
freely dispersed in the aqueous medium, or free terminal carboxylate
groups forming a surfactant bilayer. This hypothesis is supported by
the good dispersion of the nanoparticles in water.
The type of interaction between the carboxylate group and the
nanoparticle surface can be determined by the wavenumber separa-
tion, Δν, between the symmetric νs(COO) and asymmetric
νas(COO) FTIR bands. The Δν (1520–1405¼115 cm1) found was
ascribed to chelating bidentate coordination in which the interaction
between the COO group and the Fe atom was covalent [28,44].
4.7. Thermogravimetric and differential thermal analysis
TGA provided additional quantitative evidence of the magnetic
nanoparticles coating. The initial weight loss of 1.5% is due to the
evaporation of physically adsorbed water or degradation of surface
hydroxyl groups (Fig. 7). Subsequent weight loss of 24.63%
corresponds to decomposition of the surfactant [46]. We note that
previous studies showed that the number of surfactant molecules
adsorbed on the magnetite surface may vary from 2 to 3.5 mole-
cules/nm2 [47]. Thus, for functionalized magnetite nanoparticles
with 10 nm diameter the amount corresponding to the surfactant
are of the order of 25% of the total mass.
The major weight loss transitions of magnetic nanoparticles
occurred between 200 and 450 1C in a two-step process that might
indicate the formation of an oleate bilayer on the magnetite
surface. In this case, a secondary layer physically adsorbed into a
primary layer is decomposed at lower temperatures while the
primary layer chemically bound to the particle surface undergoes
desorption/decomposition at higher temperatures [48]. The DTA
data suggest that the latter process starts at 383 1C.
4.8. Heat dissipation
The speciﬁc absorption rate (SAR), which is the amount of energy
converted into heat, per unit time, per unit Fe mass, is given by [49]
SAR¼ cΔTΔt
1
mFe
ð4Þ
where c is the sample heat capacity, calculated as a mass weighted
mean value of magnetite and water, ΔT=Δt is the initial slope of the
time-dependent temperature curve, and mFe is the iron content per
gram of the ferroﬂuid.
The mean SAR value of the oleate coated nanoparticles was about
14W/g at a low ﬁeld amplitude of 15.9 kA/m and frequency of
62 kHz. Rashad et al. managed to obtain similar results with a lower
particle concentration, although a much larger magnetic ﬁeld with
41.5 kA/m amplitude and 160 kHz frequency was employed [50].
Typical SAR values between 10 and 100 W/g are commonly
reported for superparamagnetic ferroﬂuids with low particle
concentration and small crystallite sizes submitted to alternating
magnetic ﬁelds up to 18 kA/m [2–4].
Fig. 8 shows the time-dependent temperature curve of the
samples in the AC magnetic ﬁeld, with a frequency of 62 kHz and
amplitude of 15.9 kA/m. We have used a ferroﬂuid concentration
of 50 mg/mL in a 1 mL volume of water. The sample temperature
increases rapidly, reaching 42.5 1C in about 1.9 min.
We suggest that the rapid temperature increase, for low values
of the amplitude and frequency of the AC ﬁeld, originates in the
dipolar interaction between the 9 nm crystallites that compose the
60 nm nanoparticles.
This interpretation is corroborated by previous works on the
impact of the dipolar interaction on the speciﬁc absorption rate of
dextran coated iron oxide nanoparticles [51–53].
There are also interesting reports on the effects of particle inter-
actions on the cooperative behavior of multicore nanoparticles ferro-
ﬂuids for hyperthermia [54,55]. Lartigue et al. have found that the
magnetic ordering and exchange interactions within the multicore
nanostructures may lead to a 10-fold SAR increase for multicore
nanoparticle systems with respect to that of single core materials
[54].
5. Conclusions
In summary, we have reported the synthesis and characterization
of oleate coated magnetite nanoparticles with a narrow size dis-
tribution, as appropriate for magnetic hyperthermia applications.
Fig. 6. FTIR spectra of (a) magnetite particles without coating, (b) coated nano-
particles washed with ethanol to remove physically adsorbed sodium oleate and
(c) coated nanoparticles.
Fig. 7. TGA and DTA curves of coated nanoparticles.
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The synthesis is based on a simple and inexpensive co-
precipitation method with the temperature selected to optimize
the oleate coverage of the magnetite nanoparticles.
We have shown that sodium oleate successfully coated the
magnetite nanoparticles, in a weight ratio of about 25%, promoting
their stabilization into a system with narrow size distribution,
with 80% of the crystallites with dimensions in the 6 nm–12 nm
range, and average size around 9 nm.
Furthermore the DLS measurements indicate a satisfactory pat-
tern of agglomeration of the nanoparticles in aqueous medium. The
mean hydrodynamic diameter of the nanoparticles is 60.6 nm7
4.1 nm, with a small average polydispersity index (PDI) of 0.1287
0.003, as required for safe intravenous applications.
We have also shown that the magnetization measurements in
powder samples correspond to a system of dipolar coupled
magnetite crystallites, with dimensions ranging from 6 nm to
18 nm, with 83% of the particles in the 6 nm–12 nm range, in
agreement with the particle size analysis from TEM images.
The agglomeration of the crystallites in the 60 nm nanoparticles is
stable upon heating up to 200 1C. The basic structure is maintained
even when the coated nanoparticles are dried at 100 1C to obtain a
solid sample, since the TGA data suggest that the surfactant is not
decomposed until 200 1C, and when the dried samples are redis-
persed in water, the colloidal aspect is reproduced.
The system exhibits promising efﬁciency for magnetic
hyperthermia, with a speciﬁc absorption rate of 14 W/g at a low
ﬁeld amplitude of 15.9 kA/m and frequency of 62 kHz. The sample
temperature increases rapidly, reaching 42.5 1C in about 1.9 min.
We argue that the rapid heating results from the strong dipolar
interactions between the crystallites within the 60 nm nanoparti-
cles, leading to a collective behavior of the crystallites.
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